Skip to content
Screener

Opko Health OPK Q2 2026 earnings

Reported July 27, 2026 · After market close

Revenue$163.5MBeat by $32.3M
EPS-$0.01Beat by $0.07
Revenue estimate$131.2M
EPS estimate-$0.08

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$136.6M
EPS estimate-$0.07

Financials

Q2 2026

Income statement

See full
Revenue$163.6M+4.3%
Gross profit$80.0M+62.0%
Operating income-$7.0M+88.4%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
Operating cash flow-$43.5M+47.9%
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation & ratios

Valuation

as of 09/16/26
See full
Market cap$1.17B+6.2%
P/S2×+0.3×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0×0.0×
Current ratio3.3×-0.1×

Segments

By geography

See full
US$88.8M—
IE$41.7M—
CL$16.4M—
ES$8.5M—
MX$7.0M—

By product

See full
Intellectual Property And Other$46.1M—
Transfer Of Intellectual Property And Other$46.1M+208%
Rayaldee$14.3M—

FAQ

When did Opko Health report Q2 2026 earnings?
Opko Health (OPK) reported Q2 2026 earnings on July 27, 2026 after market close.
What were Opko Health's Q2 2026 revenue and EPS?
Opko Health reported revenue of $163.5M and eps of $-0.01 for Q2 2026.
Did Opko Health beat estimates in Q2 2026?
Revenue beat the consensus estimate of $131.2M by $32.3M. EPS beat the consensus estimate of $-0.08 by $0.07.
How did Opko Health's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 4.3% from $156.8M a year earlier and eps grew 94.7% from $-0.19.
Where can I find Opko Health's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-318069) and the 10-Q periodic report (0001193125-26-318090) directly on SEC EDGAR. The filing index links above go to sec.gov.